Cargando…

Omicron: Master of immune evasion maintains robust ACE2 binding

Detalles Bibliográficos
Autores principales:	Hoffmann, Markus, Zhang, Lu, Pöhlmann, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988531/ https://www.ncbi.nlm.nih.gov/pubmed/35393393 http://dx.doi.org/10.1038/s41392-022-00965-5

Ejemplares similares

Omicron spike protein: a clue for viral entry and immune evasion
por: Behrens, G. M. N., et al.
Publicado: (2022)

T-cell immunity: a barrier to Omicron immune evasion
por: Yu, Fei, et al.
Publicado: (2022)

Understanding Omicron: Transmissibility, immune evasion and antiviral intervention
por: Hoffmann, Markus, et al.
Publicado: (2022)

Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1
por: Hoffmann, Markus, et al.
Publicado: (2021)

Mutation D614G increases SARS-CoV-2 transmission
por: Arora, Prerna, et al.
Publicado: (2021)

Dalbavancin: novel candidate for COVID-19 treatment
por: Hoffmann, Markus, et al.
Publicado: (2021)

Efficient antibody evasion but reduced ACE2 binding by the emerging SARS-CoV-2 variant B.1.640.2
por: Arora, Prerna, et al.
Publicado: (2022)

Aerobic glycolysis promotes tumor immune evasion and tumor cell stemness through the noncanonical function of hexokinase 2
por: He, Haiyan, et al.
Publicado: (2023)

A new perspective on immune evasion: escaping immune surveillance by inactivating tumor suppressors
por: Mergener, Svenja, et al.
Publicado: (2022)

The determinants associated with zoonotic potential of influenza A viruses: BTN3A3 evasion mediated by residue mutation in the nucleoprotein
por: Tian, Lili, et al.
Publicado: (2023)

Up or down: where comes Omicron?
por: Liu, Zezhong, et al.
Publicado: (2022)

Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
por: Abd El-Aziz, Tarek Mohamed, et al.
Publicado: (2020)

Uncovering the IL‐1β‐PCAF‐NNT axis: A new player in ferroptosis and tumor immune evasion
por: Li, Qidong, et al.
Publicado: (2023)

Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection
por: Kalra, Rajkumar Singh, et al.
Publicado: (2021)

ACE2 level as a marker of CVD
por: Fernández-Ruiz, Irene
Publicado: (2020)

A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
por: Huo, Jiandong, et al.
Publicado: (2023)

Comparable neutralisation evasion of SARS-CoV-2 omicron subvariants BA.1, BA.2, and BA.3
por: Arora, Prerna, et al.
Publicado: (2022)

SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread
por: Wang, Xinling, et al.
Publicado: (2023)

SARS-CoV-2: A Master of Immune Evasion
por: Rubio-Casillas, Alberto, et al.
Publicado: (2022)

AFF3: a new player in maintaining XIST monoallelic expression
por: Veitia, Reiner A
Publicado: (2019)

Microbial Biotechnology: biofuels, genotoxicity reporters and robust agro‐ecosystems
por: Daniels, Craig, et al.
Publicado: (2010)

Omicron, the great escape artist
por: Flemming, Alexandra
Publicado: (2022)

Hide and seek with SARS-CoV-2: spike receptor-binding domain-specific memory B cells still recognize Omicron variant
por: Odak, Ivan, et al.
Publicado: (2022)

SARS-CoV-2 Omicron: a new challenge for pandemic and vaccine
por: Zhang, Xiantao, et al.
Publicado: (2022)

Immune Evasion of SARS-CoV-2 Omicron Subvariants
por: Ke, Hanzhong, et al.
Publicado: (2022)

Antigen‐presenting cells maintain T cells proliferation through vesicle transfer of telomeres: A new approach to telomere extension
por: Zhang, Xiaorui, et al.
Publicado: (2023)

Outsmarting SARS-CoV-2 by empowering a decoy ACE2
por: Sokolowska, Milena
Publicado: (2020)

Omicron: increased transmissibility and decreased pathogenicity
por: Bálint, Gábor, et al.
Publicado: (2022)

ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
por: Yue, Can, et al.
Publicado: (2023)

Structural Basis for the Enhanced Infectivity and Immune Evasion of Omicron Subvariants
por: Li, Yaning, et al.
Publicado: (2023)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron
por: Wang, Lidong, et al.
Publicado: (2023)

PfAlba1: master regulator of translation in the malaria parasite
por: Bunnik, Evelien M., et al.
Publicado: (2015)

A booster with SARS-CoV-2 vaccines: protection against Omicron infection
por: Hu, Yuehong, et al.
Publicado: (2022)

Omicron variant: a booster depending on infection histories
por: Wang, Jiayu, et al.
Publicado: (2023)

A suspicious role of interferon in the pathogenesis of SARS-CoV-2 by enhancing expression of ACE2
por: Su, Shan, et al.
Publicado: (2020)

Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants
por: Ou, Junxian, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle
por: Popowicz, Grzegorz Maria, et al.
Publicado: (2022)

Oxysterol-EBI2 signaling in immune regulation and viral infection
por: Daugvilaite, Viktorija, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f65tr04vqfp611ktuvo942cia5